Investigation Report on China's Trastuzumab Market 2021-2025
Request Sample
Pre-order Enquiry
Request Customization
Check Discounts
Trastuzumab is a monoclonal antibody used to treat breast cancer and stomach cancer, and is especially used for the treatment of certain HER-2 positive cancers. The original drug, HERCEPTIN was developed by Roche’s subsidiary corporation. In 2002, Trastuzumab entered the Chinese market. Currently, besides Roche, the other main manufacturer in the Chinese market is Shanghai Henlius Biotech, Inc.
According to Researcher's market research, the sales revenue of Trastuzumab in the Chinese market has an accelerated increase from 2016 to 2019. In 2020, the sales value of Trastuzumab in China was approximately CNY1.52 billion, which decreased 22.5% YoY. The CAGR of sales value of Trastuzumab in China is about 19.8% in 2016 to 2020. Researcher analyzes that as the epidemic situation has been improved and the hospitals resume their operation, the sales of Trastuzumab will have a recovery growth from 2021 to 2025.
Researcher analyzes that as the epidemic situation has been improved and the hospitals resume their operation, the sales of Trastuzumab will have a recovery growth from 2021 to 2025. In addition, the sales of Trastuzumab will also increase due to the price reduction and market expansion. Since Trastuzumab entered the Chinese market, its price has had a decreasing trend. For example, Roche’s HERCEPTIN’s price has dropped from CNY24,500 to CNY5,500. Researcher predicts that with the launch of biosimilar drugs, the price of Trastuzumab may keep falling, which will lead to an increase in sales. Moreover, as the detection of HER-2 for gastric cancer continues to be promoted, Trastuzumab will have larger market penetration in the treatment of gastric cancer in the future.
Topics Covered:
-The impact of COVID-19 on China's Trastuzumab market
- Sales value and volume of China's Trastuzumab 2016-2020
- Competitive landscape of China's Trastuzumab market
- Prices of Trastuzumab in China
- Prices of Trastuzumab in China by regions and manufacturers
- Analysis on factors affecting the development of China's Trastuzumab market
- Prospect of China's Trastuzumab market from 2021 to 2025
According to Researcher's market research, the sales revenue of Trastuzumab in the Chinese market has an accelerated increase from 2016 to 2019. In 2020, the sales value of Trastuzumab in China was approximately CNY1.52 billion, which decreased 22.5% YoY. The CAGR of sales value of Trastuzumab in China is about 19.8% in 2016 to 2020. Researcher analyzes that as the epidemic situation has been improved and the hospitals resume their operation, the sales of Trastuzumab will have a recovery growth from 2021 to 2025.
Researcher analyzes that as the epidemic situation has been improved and the hospitals resume their operation, the sales of Trastuzumab will have a recovery growth from 2021 to 2025. In addition, the sales of Trastuzumab will also increase due to the price reduction and market expansion. Since Trastuzumab entered the Chinese market, its price has had a decreasing trend. For example, Roche’s HERCEPTIN’s price has dropped from CNY24,500 to CNY5,500. Researcher predicts that with the launch of biosimilar drugs, the price of Trastuzumab may keep falling, which will lead to an increase in sales. Moreover, as the detection of HER-2 for gastric cancer continues to be promoted, Trastuzumab will have larger market penetration in the treatment of gastric cancer in the future.
Topics Covered:
-The impact of COVID-19 on China's Trastuzumab market
- Sales value and volume of China's Trastuzumab 2016-2020
- Competitive landscape of China's Trastuzumab market
- Prices of Trastuzumab in China
- Prices of Trastuzumab in China by regions and manufacturers
- Analysis on factors affecting the development of China's Trastuzumab market
- Prospect of China's Trastuzumab market from 2021 to 2025
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Details
CRI-18084449
23-Apr-2021
50
23-Apr-2021
50
License
